MEDEON BIODESIGN, INC. Medeon Biodesign, Inc. Share Price
Equities
6499
TW0006499007
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.65 TWD | +0.35% |
|
+0.83% | -8.57% |
| Sales 2022 | 298M 9.16M 732M | Sales 2023 | 196M 6.02M 482M | Capitalization | 4.29B 132M 10.54B |
|---|---|---|---|---|---|
| Net income 2022 | -434M -13.32M -1.07B | Net income 2023 | -1.2B -36.99M -2.96B | EV / Sales 2022 | 12.5 x |
| Net cash position 2022 | 1.35B 41.39M 3.31B | Net cash position 2023 | 1.96B 60.02M 4.8B | EV / Sales 2023 | 11.9 x |
| P/E ratio 2022 |
-11.7
x | P/E ratio 2023 |
-3.56
x | Employees | 39 |
| Yield 2022 |
0.86% | Yield 2023 |
-
| Free-Float | 47.57% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.35% | ||
| 1 week | +0.83% | ||
| Current month | -1.50% | ||
| 1 month | -1.16% | ||
| 3 months | -7.28% | ||
| 6 months | -11.51% | ||
| Current year | -8.57% |
1 week
41.55
43.00
1 month
41.5544.20
Current year
39.4548.75
1 year
39.4560.86
3 years
32.4780.16
5 years
23.1680.16
10 years
3.28193.48
| Managers | Title | Age | Since |
|---|---|---|---|
Yu Te Chang
CEO | Chief Executive Officer | - | 21/12/12 |
Ching Yi Chen
DFI | Director of Finance/CFO | - | - |
Greta Chang
PRN | Corporate Officer/Principal | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yu Te Chang
CEO | Chief Executive Officer | - | 21/12/12 |
Chih Lung Shen
BRD | Director/Board Member | 59 | 19/04/15 |
Hong Jen Chang
BRD | Director/Board Member | 68 | 13/01/14 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 42.65 | +0.35% | 26,773 |
| 25/04/24 | 42.5 | +0.24% | 10,448 |
| 24/04/24 | 42.4 | +0.36% | 67,671 |
| 23/04/24 | 42.25 | +0.12% | 28,303 |
| 22/04/24 | 42.2 | -0.24% | 31,099 |
End-of-day quote Taipei Exchange, April 25, 2024
More quotes
Medeon Biodesign, Inc. is a Taiwan-based company principally engaged in the research, development, manufacture and sales of medical equipment. The Company's main products include medical apparatus and instruments used in laparoscopic minimally invasive surgeries and cardiac catheter-related minimally invasive surgeries. The Company distributes its products in domestic market and to overseas markets.
Calendar
02/05/2024
- Q1 2024 Earnings Release (Projected)
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -8.57% | 120M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- 6499 Stock
